Buy Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) 500mcg (60 Capsules)

• Dosage and Use:

  • Typical dosages can range, but commonly it’s 2 capsules per serving, which can be taken with food. Buy Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) 500mcg
  • The peptide is typically administered via capsule.

• Side Effects:

  • As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
  • It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.

  Molecular Formula: C₂₀H₃₃N₅O₉
  Molecular Weight: 487.5 g/mol
  Sequence: Ac-Ser-Asp-Lys-Pro
  Purity: >99%
  Capsule Size: 500mcg per capsule
  Bottle Size: 60 capsules
  Storage: Room temperature, protect from moisture

  Product Overview

  Thymosin Beta-4 Fragment (Ac-SDKP) represents revolutionary anti-inflammatory peptide technology designed for comprehensive cardiovascular, pulmonary, and tissue repair research applications. This naturally occurring tetrapeptide, derived from the N-terminal sequence of thymosin β4, demonstrates exceptional ability to prevent fibrosis, reduce inflammation, and promote angiogenesis through multiple pathway modulation. Unlike broad anti-inflammatory agents, Ac-SDKP specifically targets macrophage activity and TGF-β signaling while maintaining physiological tissue repair mechanisms. Buy Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) 500mcg

  Revolutionary Anti-Fibrotic Mechanism

  Ac-SDKP functions as a potent inhibitor of tissue fibrosis through multiple complementary pathways including suppression of transforming growth factor-β, inhibition of myofibroblast differentiation, and modulation of macrophage activation. The peptide preferentially degrades via angiotensin-converting enzyme, creating a unique therapeutic relationship where ACE inhibitors increase Ac-SDKP levels while Ac-SDKP mediates many beneficial effects of ACE inhibition. This dual mechanism provides comprehensive protection against organ damage in cardiovascular, renal, and pulmonary systems. Buy Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) 500mcg

  Primary Research Applications: Buy Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) 500mcg

  Cardiovascular Protection Studies

  Extensive clinical validation demonstrates significant reduction in cardiac fibrosis, left ventricular hypertrophy prevention, and improved survival rates following myocardial infarction. Research shows 31.8% vs 56.9% mortality reduction and decreased cardiac rupture rates from 51% to 27% in experimental models. Studies reveal enhanced endothelial cell migration, improved angiogenesis, and reduced inflammatory cell infiltration, positioning it as valuable tool for investigating heart failure prevention and cardiac repair mechanisms.

  Pulmonary Fibrosis Research

  Comprehensive studies demonstrate both preventive and therapeutic effects against bleomycin-induced pulmonary fibrosis with reduced mortality, inflammation, and collagen deposition. Research shows inhibition of TGF-β signaling, decreased α-SMA expression, and prevention of epithelial-mesenchymal transition. Applications include investigating idiopathic pulmonary fibrosis mechanisms, lung injury repair pathways, and novel anti-fibrotic therapeutic approaches.

  Renal Protection Studies

  Research reveals significant nephroprotective effects including reduced albuminuria, preserved glomerular filtration rate, and decreased chronic kidney disease progression. Studies demonstrate prevention of tubulointerstitial fibrosis, reduced inflammatory cell infiltration, and improved renal function in 5/6 nephrectomy models. Applications encompass diabetic nephropathy research, hypertensive kidney disease studies, and acute kidney injury prevention investigations.

  Stroke & Neuroprotection Research

  Clinical studies demonstrate substantial reduction in stroke-induced brain infarct volume and neurological deficits when combined with tissue plasminogen activator. Research shows enhanced blood-brain barrier function, reduced fibrin extravasation, and decreased microglial activation. Studies reveal increased hippocampal neurogenesis and improved cognitive function, making it valuable for investigating cerebral ischemia recovery and neurodegenerative disease prevention.

  Cancer Treatment Support

  Research demonstrates significant protection against chemotherapy and radiation-induced organ toxicity including cardiac, renal, and bone marrow protection. Studies show reduced mortality from doxorubicin cardiotoxicity and enhanced bone marrow recovery following radiation therapy. Applications include investigating treatment-related side effect prevention and improving cancer therapy tolerance through organ protection strategies.

  Mechanism of Action

  Macrophage Inhibition: Prevention of bone marrow stem cell differentiation into inflammatory macrophages
  TGF-β Suppression: Direct inhibition of transforming growth factor-β expression and signaling pathways
  Angiogenesis Promotion: Enhanced endothelial cell migration and blood vessel formation
  Anti-Proliferative Effects: Cell cycle arrest in G0/G1 phase preventing excessive tissue proliferation
  MEK-ERK Modulation: Regulation of mitogen-activated protein kinase signaling pathways
  ACE Pathway Integration: Synergistic effects with angiotensin-converting enzyme inhibition

  Research Advantages

  Oral Bioavailability: Convenient capsule form providing consistent dosing and improved compliance
  Multi-System Protection: Simultaneous cardiovascular, pulmonary, renal, and neurological applications
  Clinical Foundation: Extensive validation across multiple disease models with proven safety profiles
  Anti-Fibrotic Specificity: Targeted prevention and reversal of pathological scarring processes
  Synergistic Potential: Enhanced efficacy when combined with ACE inhibitors and standard therapies
  Natural Origin: Endogenous tetrapeptide with established physiological role and safety profile
  Ready-to-Use Format: No reconstitution required enabling immediate research application

  Quality Specifications

  Every Ac-SDKP capsule batch undergoes comprehensive quality control:

  • HPLC-MS purity analysis confirming >99% purity
  • Tetrapeptide sequence verification (Ac-Ser-Asp-Lys-Pro)
  • Molecular weight confirmation at 487.5 g/mol
  • CAS number validation (120081-14-3)
  • PubChem CID verification (65938)
  • Endotoxin testing (<0.1 EU/mg)
  • Certificate of Analysis provided with shipment

  Storage & Administration

  Store capsules at room temperature in sealed bottle. Protect from moisture and excessive heat. Capsules maintain stability for 24 months when stored properly. For research applications, capsules may be opened and contents dissolved in appropriate research media. Each capsule contains precisely measured 500mcg dose enabling consistent research protocols.

  Research Use Only: Not for human or veterinary therapeutic applications. Handle according to laboratory safety protocols and institutional research guidelines.